PubRank

K K Tanabe

Author PubWeight™ 48.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000 2.59
2 Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A 1998 2.29
3 Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998 2.17
4 Surgical management of phyllodes tumors. Arch Surg 1999 2.16
5 Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999 1.92
6 Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. Br J Dermatol 2014 1.53
7 Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998 1.48
8 Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J 2000 1.41
9 Attitudes and opinions toward surgical research. A survey of surgical residents and their chairpersons. Ann Surg 1996 1.28
10 Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res 1999 1.27
11 Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995 1.27
12 Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res 2000 1.20
13 Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999 1.15
14 Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer 1993 1.13
15 Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist 1999 1.06
16 An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma. FASEB J 2000 1.06
17 Multimodality management of Merkel cell carcinoma. Arch Surg 1999 1.04
18 Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus. Ann Surg 1996 1.02
19 Glutamine as a regulator of DNA and protein biosynthesis in human solid tumor cell lines. Ann Surg 1996 1.01
20 Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 1999 1.00
21 Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil. Cancer Res 2001 0.98
22 CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 1995 0.97
23 Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector. Ann Surg 1998 0.95
24 CD44s expression in human colon carcinomas influences growth of liver metastases. Int J Cancer 2000 0.92
25 Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus. Cancer Res 2000 0.92
26 Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J Biol Chem 1996 0.91
27 Surgical management of primary cutaneous melanomas of the hands and feet. Ann Surg 1997 0.90
28 Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Cancer 2000 0.88
29 Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases. Arch Dermatol 2000 0.88
30 O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells. Biochem Biophys Res Commun 1996 0.88
31 Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer 1999 0.87
32 Spread of human cancer cells occurs with probabilities indicative of a nongenetic mechanism. Br J Cancer 2005 0.85
33 Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice. Cancer Gene Ther 2008 0.85
34 Expression of CD44 splicing isoforms in lung cancers: dominant expression of CD44v8-10 in non-small cell lung carcinomas. Int J Oncol 1998 0.85
35 The effect of ganciclovir on herpes simplex virus-mediated oncolysis. J Surg Res 1997 0.85
36 Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis. Cancer Gene Ther 2013 0.82
37 Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation. Cancer Gene Ther 2011 0.82
38 Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res 2001 0.82
39 Glucocorticoid-dependent induction of interleukin-6 receptor expression in human hepatocytes facilitates interleukin-6 stimulation of amino acid transport. Ann Surg 1996 0.81
40 Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 1995 0.80
41 The carboxyl-terminal fragment of osteopontin suppresses arginine-glycine-asparatic acid-dependent cell adhesion. Biochem Mol Biol Int 1998 0.79
42 Radiofrequency ablation for primary and metastatic liver tumors. Cancer Treat Res 2001 0.78
43 Multidisciplinary management of metastatic colorectal cancer. Surg Oncol 2000 0.78
44 Ephemeral seeds: microembolization of tumor cells during surgery. Ann Surg Oncol 1999 0.75
45 Gene therapy for liver tumors. Surg Oncol Clin N Am 1998 0.75
46 Mapping and regulation of the tumor-associated epitope recognized by monoclonal antibody RS-11. J Biol Chem 2000 0.75
47 Cancer gene therapy. Surg Oncol Clin N Am 1998 0.75
48 Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma. J Fla Med Assoc 1997 0.75
49 Cell adhesion in tumor invasion. Ann Surg Oncol 1995 0.75
50 Influence of p53 on herpes simplex virus type 1 vectors for cancer gene therapy. J Gastrointest Surg 2000 0.75